Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-4465

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-4465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description for Oxcarbazepine Tablets, with a dosage of 600 mg and a pack containing 30 tablets. The manufacturer is Breckenridge located in Boca Raton, FL. It is repackaged by RemedyRepack Inc. with an NDC number of 70518-4466-00. The lot number and expiration date are missing. The recommended storage temperature is between 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F). It is important to keep this medication out of the reach of children.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

This text provides information on the exit rate and the results of the log-rank test with a p-value of 0.0001. It also includes a table showing time on trial from the second day, with specific time points and days listed for the Treatment Group comparison. The Treatment Group consists of Oxcarbazepine and Placebo.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

This text provides information on seizure rate analysis using the log-rank test with a p-value of 0.046. It also includes a table showing the number of days from the 1st dose to the 1st seizure in the treatment groups Oxcarbazepine and Placebo.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

The text provides information about the exit rate and the log-rank test result with a p-value of 0.0001. It also includes a graph or data table showing time to exit in days for two treatment groups: HIGH and LOW.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

The text provides information on the exit rate with a p-value of 0.0001 from a log-rank test. It also includes a graph showing time to exit in days for a treatment labeled as "Treatment Grot - HIGH."*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.